Capitalisation Pro Kneeland C. Youngblood joins Scientific Games governance

Nasdaq-listed industry technology group Scientific Games Corporation (SGC), has expanded its governance committee, confirming the appointment of Kneeland C. Youngblood as a new company director.

An expert in large-scale financing projects, corporate recapitalisation and political stakeholder management, Youngblood will serve as an SGC advisor and member of the Nasdaq enterprises’ compensation and compliance committees.

A qualified physician, Youngblood is the founding partner of US healthcare and pharmaceutical private equity firm Pharos Capital LLC.

A Texas native Youngblood also serves as director of Mallinckrodt plc, a speciality pharmaceutical company, and as a director of TPG Pace Holdings.  Furthermore, Youngblood has served as a member of the US Council of Foreign Relations.

“We are pleased that the Board elected Kneeland as a new director,” said Barry Cottle, Group Chief Executive officer of Scientific Games.

“He brings valuable experience in business, operations and strategy to our team. We look forward to Kneeland’s contributions as we continue to drive growth in our core business and take advantage of new opportunities to engage players and bring value to our customers.”

Check Also

Catena orders 10% buyback of Stockholm shares 

The board of Catena Media Plc has authorised the buyback of in excess of 7 …

Codere H1 dragged by continued global pandemic headwinds

Codere SA continues to mitigate the impact of COVID-19 pandemic restrictions on its business lines, …

Gambling.com rides high off strong maiden Nasdaq results 

Gambling.com Group has underscored its credentials as a new US Nasdaq enterprise, recording double-digit growth …